Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-03

Clinical Trial Update: Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial of association drugs in dermatitis was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Azidus Brasil | Conditions: Dermatitis | Phase 3 | Status: WITHDRAWN